Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
812.00    4.00 (0.50%)
Bid:
810.00
Ask:
812.00
Spread: 2.00 (0.247%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Acquisition

28 Jul 2017 12:20

RNS Number : 4554M
Savills PLC
28 July 2017
 

SAVILLS ACQUISITION OF AGUIRRE NEWMAN

 

Further building the scale of Savills European real estate services business

 

Savills plc, one of the world's leading real estate advisory firms, announces the proposed acquisition of Aguirre Newman S.A. ("Aguirre Newman"), the leading Spanish independent real estate advisory business, for up to €67 million payable in instalments over five years from completion. The acquisition is scheduled to complete by 30th November 2017 following satisfaction of customary regulatory and closing conditions.

 

Aguirre Newman was founded in 1988. The business employs more than 400 staff and is headquartered in Madrid, with offices in Barcelona, Malaga, Lisbon and Porto (Portugal). The firm provides agency, investment, management, architectural, consultancy, valuation, planning, corporate finance and asset management services.

 

The businesses of Aguirre Newman and Savills in Spain will be integrated with Savills existing Spanish business employing 70 people in offices in Madrid and Barcelona, and will initially operate in Spain under the Savills Aguirre Newman brand. The principals of Aguirre Newman, Santiago Aguirre and Stephen Newman, and the Head of Savills Spain, Rafael Merry del Val, will be appointed to the Board of the combined businesses.

 

Commenting on the acquisition, Jeremy Helsby, Savills CEO, said: "The acquisition of Aguirre Newman combined with our existing Spanish business provides us with a significant footprint in Spain, a market where we see exciting long term growth opportunities. It follows Savills strategy to develop multi-service offerings and expand our presence in key Continental European markets."

 

For the year ended 31 December 2016, the gross turnover of the continuing operations of Aguirre Newman was €69 million.

 

The purchase consideration will be funded from Savills cash and existing banking facilities. On completion, Savills will pay €42 million. Deferred consideration of up to €5 million is payable on each anniversary of completion for the next five years totalling €25 million.

 

 

 

For further information please contact:

 

Savills

Jeremy Helsby, Chief Executive Officer, Tel: +44 20 7409 8934

Simon Shaw, Chief Financial Officer

 

Tulchan Communications Tel: +44 20 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKFDDDBKDOOB
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.